The global nausea relief chews market revenue was around US$ 416.73 million in 2022 and is estimated to reach US$ 792.30 million by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2023 to 2031.
Nausea relief chews are a kind of over-the-counter medication utilized to offer relief from vomiting and nausea. These chews are typically formulated with natural ingredients such as peppermint, ginger, or chamomile, which have been traditionally used to reduce gastrointestinal discomfort. Nausea relief chews are available in various flavors and are designed to be swallowed and chewed like candy.
Market Driving Factors
Chemotherapy, which has adverse symptoms like nausea and vomiting, is utilized as a routine treatment for all types of cancer due to the rise in cancer occurrences. In addition, nausea relief chews made from herbal and natural products utilized for the relieving of nausea and vomiting are estimated to drive the market growth.
The availability and possible advantages of nausea relief chews are becoming more widely known worldwide due to several awareness campaigns, commercials, healthcare professionals, and internet resources. These factors are also driving the demand of the market.
Growing research and development efforts are expected to produce new, faster-acting, and more effective formulations of chews for nausea relief that include unique combinations of active ingredients. Additionally, the development of sustained-release or extended-release chews, which release active ingredients gradually over an extended time. Thus, this factor is estimated to boost the market growth.
Strict regulatory compliance that businesses must adhere to when manufacturing and distributing these products, as well as the use of a narrow range of indications like morning sickness, motion sickness, and nausea from chemotherapy. Such these factors limit the market growth.
Regional Analysis
North America dominated the market in terms of the highest growth rate and is estimated to maintain its dominance over the forecast period. This can be attributed to its substantial use in cancer treatment, specifically for patients experiencing radiation and chemotherapy therapy, as these chews are specially designed to alleviate vomiting and nausea, which can be the side effects of these treatments. Furthermore, there is an increase in need and demand for efficient nausea relief chews due to the surged cancer incidences in the region.
The Asia Pacific is predicted to emerge as the fastest growing region in the market. This is due to its ongoing increase in the aging population in nations like China and India, who are more likely to experience nausea-related health problems, and the existence of favorable laws and policies supporting the development of Over-the-counter (OTC) pharmaceuticals including nausea relief products. Additionally, the increasing proliferation of busy urban lifestyles, erratic eating habits, and high stress levels, especially in cities, is particularly contributing to gastrointestinal problems and nausea. These rising problems are likely to positively promote the demand for nausea relief chews as they offer a rapid and convenient solution for people with hectic lifestyles.
Segmentation Insights
Indication Insight
The motion sickness and seasickness segment accounted for the largest share of the market. This is due to a substantial number of people experiencing motion sickness globally and the increase in the number of people traveling by air, which led to a higher majority of motion sickness, mainly during long-haul flights. Furthermore, the surge in availability of over-the-counter nausea relief chews at airports, pharmacies, and travel centers makes them easily available to travelers and contributes to their usage.
The gastroesophageal reflux disease (GRED) segment is estimated to dominate the market in terms of the highest growth during the forecast period. This is mainly owing to a surge in the prevalence of GRED globally and a rise in preference for immediate relief to alleviate discomfort among people with GRED-related nausea. In addition, these chews are gradually becoming an effectual alternative or complementary alternative to prescriptions for handling GRED nausea more effectively.
Distribution Channel Insight
The online sales segment is estimated to witness the highest growth rate during the projection period. This is due to a surge in online shopping trends and an extreme shift in customer preferences towards online shopping platforms for healthcare products owing to their multiple beneficial features, including accessibility and convenience, broader product selection from various brands, complete product information, and cost comparison and better discounts, among many others.
The hospital pharmacies segment dominates the market in terms of revenue share. This is due to the larger patient population in hospitals owing to the existence of healthcare professionals, including specialists, physicians, and nurses, who play an essential role in prescribing medications, including nausea relief chews.
Prominent Companies
Segmentation Outline
The global nausea relief chews market segmentation focuses on Indication, Distribution Channel, and Region.
By Indication
By Distribution Channel
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL NAUSEA RELIEF CHEWS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: NAUSEA RELIEF CHEWS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL NAUSEA RELIEF CHEWS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL NAUSEA RELIEF CHEWS MARKET, BY INDICATION
5.1 OVERVIEW
5.2 GASTROESOPHAGEAL REFLUX DISEASE
5.3 MOTION SICKNESS AND SEASICKNESS
6 GLOBAL NAUSEA RELIEF CHEWS MARKET, BY DISTRIBUTION CHANNEL
6.1 OVERVIEW
6.2 ONLINE SALES
6.3 SUPERMARKETS & HYPERMARKETS
6.4 HOSPITAL PHARMACIES
6.5 OTHERS
7 GLOBAL NAUSEA RELIEF CHEWS MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL NAUSEA RELIEF CHEWS MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 CIPLA
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 EMETROL CHEWABLES
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 GINGER PEOPLE
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 MEGAFOOD
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 MIGHTY PETZ
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 PEPTO BISMOL
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 PINK STORK
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 PRESTIGE CONSUMER HEALTHCARE INC
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 PSI BANDS
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 SANOFI
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.11 SEA CALM
9.11.1 OVERVIEW
9.11.2 FINANCIAL PERFORMANCE
9.11.3 PRODUCT OUTLOOK
9.11.4 KEY DEVELOPMENTS
9.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.12 SEA-BAND
9.12.1 OVERVIEW
9.12.2 FINANCIAL PERFORMANCE
9.12.3 PRODUCT OUTLOOK
9.12.4 KEY DEVELOPMENTS
9.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.13 THREE LOLLIES
9.13.1 OVERVIEW
9.13.2 FINANCIAL PERFORMANCE
9.13.3 PRODUCT OUTLOOK
9.13.4 KEY DEVELOPMENTS
9.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.14 UPSPRING
9.14.1 OVERVIEW
9.14.2 FINANCIAL PERFORMANCE
9.14.3 PRODUCT OUTLOOK
9.14.4 KEY DEVELOPMENTS
9.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.15 WEBBER NATURALS
9.15.1 OVERVIEW
9.15.2 FINANCIAL PERFORMANCE
9.15.3 PRODUCT OUTLOOK
9.15.4 KEY DEVELOPMENTS
9.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved